Spyre Therapeutics
Presence
Spyre Therapeutics is a company listed under the stock ticker AGLE (US).
Acquisition, funding and merger involving Spyre Therapeutics.
- Spyre Therapeutics will change its company name to Spyre Therapeutics on Nov 28, 2023. (posted on November 28 2023).
Executives
View the org chart displaying its 27 main executives
Most searched biographies at Spyre Therapeutics
- Cameron Turtle, Chief Executive Officer and Director
- Jeffrey Albers, Director
- Sandra Milligan, Director
Popular executive movements at Spyre Therapeutics
- Sandra Milligan has joined the company as Director (posted on May 16 2024).
- Mark Mckenna has joined the company as Director (posted on February 6 2024).
- Laurie Stelzer has joined the company as Director (posted on November 28 2023).
Click here to view some more movements at Spyre Therapeutics
Create your alert
to follow the executive moves at Spyre Therapeutics.
Biotechnology
Spyre Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by Spyre Therapeutics
- Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Announces Grants of Inducement Awards
- Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Announces Grants of Inducement Awards
- Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics to Participate in Upcoming November Investor Conferences
- Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Announces Grants of Inducement Awards
- Aeglea BioTherapeutics to Participate in Upcoming September Conference
- Aeglea BioTherapeutics Announces Reverse Stock Split
- Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
- Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
- Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma
- View more press releases Close
Social media about Spyre Therapeutics
- Spyre Therapeutics on Wikipedia, Google News & Yahoo Finance
- Spyre Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Michael Henderson 
Call Spyre Therapeutics at +1 512...
